NCT06927765

Brief Summary

Acute appendicitis is the most common acute abdomen, and a small number of patients can progress to perforated appendicitis, which has significantly higher complications than non-perforated appendicitis. Appendectomy is the only option for treating perforated appendicitis. Optimizing the diagnosis and treatment of perforated appendicitis is of great significance to improve its clinical outcomes and save medical resources. There is a consensus that drainage should not be placed after surgery for non-perforated appendicitis, but the decision to place drainage for perforated appendicitis remains controversial. Several retrospective studies have shown no benefit in postoperative recovery and hospital stay, and may lead to increased infectious complications and longer hospital stays. A small number of prospective studies have shown similar conclusions, but the sample size is too small, most of them are children, and there is a lack of large-scale multicenter studies. The investigators' preliminary retrospective survey suggests that in China, most surgeons still commonly place drains for peace of mind after surgery with perforated appendicitis in adults without seeing a clear benefit, so there is a need for a multicenter prospective randomized controlled study to evaluate the need for drainage placement after perforated appendicitis and to guide clinical practice with evidence. To study the effect of abdominal drainage on the postoperative clinical outcomes of adult patients with perforated appendicitis, mainly including: infectious complications (residual infection or abscess in the abdominal cavity, incision infection, fecal fistula, etc.), case fatality rate, pain score, length of hospital stay (LOS), quality of life (QOL) score, etc.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 23, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 15, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

December 23, 2024

Last Update Submit

April 7, 2025

Conditions

Keywords

Perforated appendicitisabdominal drainage

Outcome Measures

Primary Outcomes (3)

  • Incision infection rate

    Superficial tissue infections, such as those at the site of the surgical Trocar foramen (epidermal or subcutaneous), do not enter the abdominal cavity

    From enrollment to 30 days postoperatively

  • Incidence of intra-abdominal abscess

    Residual infection in the abdominal cavity forms an abscess.The incidence of intra-abdominal abscess after surgery will be compared between the two groups

    From enrollment to 30 days postoperatively

  • Incidence of fecal leakage

    Dehiscence of the stump of the appendix causes fecal residue to enter the abdominal cavity

    From enrollment to 30 days postoperatively

Secondary Outcomes (3)

  • Length of hospital stay

    From enrollment to 30 days postoperatively

  • Pain scores

    From enrollment to 30 days postoperatively

  • Quality of life scores

    From enrollment to 30 days postoperatively

Study Arms (1)

Place an abdominal drain

Place an abdominal drain

Other: No abdominal drain is placed

Interventions

No abdominal drain is placed

Place an abdominal drain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with acute perforated appendicitis \>18 years of age

You may qualify if:

  • Age: ≥ 18 years old (no upper limit);
  • Perforated appendicitis or suspected perforated appendicitis who intends to undergo laparoscopic appendectomy;
  • Patients and their families (or legal representatives) are able to understand the study protocol and voluntarily participate in this study, and sign informed consent.

You may not qualify if:

  • Whole abdominal pus was found during the operation;
  • Open or laparoscopic conversion to open appendectomy;
  • Appendiceal tumors (including postoperative pathology)
  • Pregnancy or perinatal period;
  • AIDS, tuberculosis, liver cirrhosis, uremia, aplastic anemia, essential thrombocytopenia, inflammatory bowel disease, organ transplantation;
  • Long-term or preoperative use of immunosuppressants/glucocorticoids/tumor chemotherapy drugs/targeted drugs/immunodrugs;
  • Malignant tumors (including leukemia and lymphoma) disease status, recurrence/metastasis, and perioperative period;
  • Drunk, drug abuse/drug addicts;
  • Organ dysfunction/failure;
  • Those who are transferred to the ICU for various reasons;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Affiliated Hospital of Qingdao University

Qingdao, Shandong, 266000, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Excision of the appendix Intraperitoneal pus

MeSH Terms

Conditions

Appendicitis

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2024

First Posted

April 15, 2025

Study Start

June 1, 2024

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

secrecy

Locations